<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02044939</url>
  </required_header>
  <id_info>
    <org_study_id>2011_23/1917</org_study_id>
    <secondary_id>2012-A00347-36</secondary_id>
    <nct_id>NCT02044939</nct_id>
  </id_info>
  <brief_title>Pulmonary Rehabilitation in Patients With Sarcoidosis</brief_title>
  <official_title>Pulmonary Rehabilitation in Fibrotic Pulmonary Sarcoidosis (Stage IV): Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to assess the improvement of daily activity in subjects
      with Stage IV Pulmonary Sarcoidosis one year after the conduct of a pulmonary rehabilitation
      program.

      The secondary objectives are the following:

        -  assess the improvement of daily activity at several times : 2, 6 and 12 months after the
           beginning of a pulmonary rehabilitation program

        -  assess the improvement of exercise capacity by tests used in medical practice

        -  assess the correlation between daily activity and exercise capacity

        -  assess the improvement of dyspnea

        -  assess the improvement of quality of life and psychological state
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of the study is to assess the improvement of daily activity in subjects
      with Stage IV Pulmonary Sarcoidosis one year after the conduct of a pulmonary rehabilitation
      program

      The secondary objectives are the following :

        -  assess the improvement of daily activity at several times : 2, 6 and 12 months after the
           beginning of a pulmonary rehabilitation program

        -  assess the improvement of exercise capacity by tests used in medical practice

        -  assess the correlation between daily activity and exercise capacity

        -  assess the improvement of dyspnea

        -  assess the improvement of quality of life and psychological state
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 10, 2012</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Daily activity assessed by time (in minutes) spent in moderate activity (superior to 2,5 MET)</measure>
    <time_frame>12 months</time_frame>
    <description>In everyday life, it corresponds to a walking in 5 km/h or in domestic chores. This measure will be realized by using Armband's accelerometer, in ambulatory. The measure will be realized over a period of 4 full days including the weekend.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Daily activity assessed by time spent in moderate activity (superior to 2,5 MET)</measure>
    <time_frame>2 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>exercise capacity assessed by symptom-limited cardiopulmonary exercise test, 6 minutes walk test, endurance test on bicycle, St Etienne questionnaire, 6 minutes stepper test</measure>
    <time_frame>2, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MRC scale for dyspnea</measure>
    <time_frame>2, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire to evaluate quality of life and/or psychological state : VSRQ</measure>
    <time_frame>2, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire to evaluate quality of life and/or psychological state : MRF 28</measure>
    <time_frame>2, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire to evaluate quality of life and/or psychological state : HAD</measure>
    <time_frame>2, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire to evaluate quality of life and/or psychological state : FAS</measure>
    <time_frame>2, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire to evaluate quality of life and/or psychological state : DIRECT</measure>
    <time_frame>2, 6 and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Stage 4 Pulmonary Sarcoidosis</condition>
  <arm_group>
    <arm_group_label>Pulmonary rehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sarcoidosis patients will realize a pulmonary rehabilitation program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Sarcoidosis patients who do not achieve a respiratory rehabilitation program but will have physical activity counseling.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pulmonary rehabilitation program</intervention_name>
    <description>Pulmonary rehabilitation program should follow ATS/ERS Guidelines (2006)</description>
    <arm_group_label>Pulmonary rehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stage IV Sarcoidosis

          -  No hospitalization for respiratory distress in the 3 months preceding the inclusion

          -  Dyspnea on exertion

          -  Age over 18 years

        Exclusion Criteria:

          -  Physical disability does not allow the creation of a rehabilitation program

          -  Inability to give written consent to the study

          -  Refusal of contraception in women of childbearing age

          -  Inability to participate in the entire study

          -  No cover by the social security system

          -  Inability to perform self-questionnaires etude

        The trial does not include special populations include:

          -  Pregnant women

          -  Breastfeeding women

          -  People in emergencies

          -  Persons unable to consent

          -  Persons deprived of liberty
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benoît WALLAERT, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique des Maladies Respiratoires, CHRU de Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frédéric BART, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Pneumologie, CH Béthune</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dominique VALEYRE, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de pneumologie, Hôpital Avicenne AP-HP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dominique ISRAEL-BIET, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Pneumologie, Hôpital européen Georges Pompidou. AP-HP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean AMOURETTE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Pneumologie, CH Arras</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yves PACHECO, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Lyon Sud</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vincent COTTIN, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Pneumologie, Hôpital Louis Pradel, Lyon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martine REYNAUD-GAUBERT, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Nord, APHM Marseille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sylvie LEROY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Pneumologie, Hôpital Pasteur - Pavillon H, CHU de Nice</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gaëtan DESLEE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Maison Blanche, CHU de Reims</affiliation>
  </overall_official>
  <overall_official>
    <last_name>François STEENHOUWER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Pneumologie, Hôpital Victor Provo, Roubaix</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alain DIDIER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique des Voies Respiratoires, Hôpital Larrey, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benoît WALLAERT, MD PhD</last_name>
    <phone>+33 320 44 59 48</phone>
    <email>benoit.wallaert@chru-lille.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Morgane FOULON, CRA</last_name>
    <phone>+33 320 44 59 48</phone>
    <phone_ext>30966</phone_ext>
    <email>morgane.foulon@chru-lille.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinique des Maladies Respiratoires, CHRU de LILLE</name>
      <address>
        <city>Lille</city>
        <state>Nord</state>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benoît WALLAERT, MD PhD</last_name>
      <phone>+33 320 44 59 48</phone>
      <email>benoit.wallaert@chru-lille.fr</email>
    </contact>
    <contact_backup>
      <last_name>Morgane FOULON, CRA</last_name>
      <phone>+ 33 320 44 59 48</phone>
      <email>morgane.foulon@chru-lille.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Benoît WALLAERT, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Pneumologie, CH Béthune</name>
      <address>
        <city>Béthune</city>
        <state>Pas de Calais</state>
        <zip>62408</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frédéric BART, MD</last_name>
      <phone>+33 321 64 43 36</phone>
      <email>fbart@ch-bethune.fr</email>
    </contact>
    <investigator>
      <last_name>Frédéric BART, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Pneumologie, CH Arras</name>
      <address>
        <city>Arras</city>
        <zip>62000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean AMOURETTE, MD PhD</last_name>
      <phone>+33 3 21 21 13 46</phone>
      <email>jean.amourette@ch-arras.fr</email>
    </contact>
    <investigator>
      <last_name>Jean AMOURETTE, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de pneumologie, Hôpital Avicenne AP-HP</name>
      <address>
        <city>Bobigny</city>
        <zip>93009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Nord, APHM Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Service de Pneumologie, Hôpital Pasteur - Pavillon H, CHU de Nice</name>
      <address>
        <city>Nice</city>
        <zip>06002</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Service de Pneumologie, Hôpital européen Georges Pompidou. AP-HP</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique ISRAEL-BIET, MD PhD</last_name>
      <phone>+33 1 56 09 34 89</phone>
      <email>dominique.israel-biet@egp.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Dominique ISRAEL-BIET, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Pierre Benite</city>
        <zip>69310</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves PACHECO, MD PhD</last_name>
      <phone>+33 4.78.86.15.18</phone>
      <email>yves.pacheco@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Yves PACHECO, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Maison Blanche, CHU de Reims</name>
      <address>
        <city>Reims</city>
        <zip>51100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Service de Pneumologie, Hôpital Victor Provo</name>
      <address>
        <city>Roubaix</city>
        <zip>59056</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique des Voies Respiratoires, Hôpital Larrey</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2014</study_first_submitted>
  <study_first_submitted_qc>January 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2014</study_first_posted>
  <last_update_submitted>May 17, 2017</last_update_submitted>
  <last_update_submitted_qc>May 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sarcoidosis, pulmonary rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoidosis</mesh_term>
    <mesh_term>Sarcoidosis, Pulmonary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

